Signaling regulation of fetoplacental angiogenesis

Journal of Endocrinology

Volumn 212, Issue 3, 2012, Pages 243-255

  Wang, Kai ^a   Zheng, Jing ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; NITRIC OXIDE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2; PHOSPHOPROTEIN PHOSPHATASE 3; PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; FETUS CIRCULATION; FETUS GROWTH; IN VITRO STUDY; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; CELL DIVISION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; PHOSPHOPROTEIN PHOSPHATASES; PLACENTAL CIRCULATION; PREGNANCY; PROTEIN KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863261022     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0296     Document Type: Review

References (153)

1. Aitsebaomo J, Portbury AL, Schisler JC & Patterson C 2008 Brothers and sisters: molecular insights into arterial-venous heterogeneity. Circulation Research 103 929-939. (doi:10.1161/CIRCRESAHA.108.184937)
2. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM & Cohen P 1995 Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Current Biology 5 283-295. (doi:10.1016/S0960-9822(95)00059-5)
3. Alexander G 1974 Birth weight of lambs. Influences and consequences. In Ciba Foundation Symposium 27: Size at Birth, pp 215-239. Eds K Elliott & J Knight. New York: Elsevier Publisher.
4. Aramburu J, Heitman J & Crabtree GR 2004 Calcineurin: a central controller of signaling in eukaryotes. EMBO Reports 5 343-348. (doi:10.1038/sj.embor.7400133)
5. Arnal JF, Tack I, Besombes JP, Pipy B & Negre-Salvayre A 1996 Nitric oxide and superoxide anion production during endothelial cell proliferation. American Journal of Physiology 271 C1521-C1526.
6. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP & Stewart DJ 1998 Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circulation Research 82 1007-1015.
7. Barcroft J & Barron DH 1946 Observations upon the form and relations of the maternal and fetal vessels in the placenta of the sheep. Anatomical Record 94 569-595. (doi:10.1002/ar.1090940403)
8. Barford D, Das AK & Egloff MP 1998 The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annual Review of Biophysics and Biomolecular Structure 27 133-164. (doi:10.1146/annurev.biophys.27.1.133)
9. Baudin B, Bruneel A, Bosselut N & Vaubourdolle M 2007 A protocol for isolation and culture of human umbilical vein endothelial cells. Nature Protocols 2 481-485. (doi:10.1038/nprot.2007.54)
10. Benirschke K, Kaufmann P & Baergen R 2006a Architecture of normal villous trees. In Pathology of the Human Placenta, 5th edn, pp 121-173. Eds Benirschke K, Kaufmann P & Baergen R. New York: Springer ScienceC Business Media.
11. Benirschke K, Kaufmann P & Baergen R 2006b Anatomy and pathology of the umbilical cord. In Pathology of the Human Placenta, 5th edn, pp 380-451. Eds Benirschke K, Kaufmann P & Baergen R. New York: Springer ScienceCBusiness Media.
12. Bertout JA, Patel SA & Simon MC 2008 The impact of O2 availability on human cancer. Nature Reviews. Cancer 8 967-975. (doi:10.1038/nrc2540)
13. Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ & Fineman JR 1999 Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. American Journal of Physiology 277 H1849-H1856.
14. Blumer KJ & Johnson GL 1994 Diversity in function and regulation of MAP kinase pathways. Trends in Biochemical Sciences 19 236-240. (doi:10.1016/0968-0004(94)90147-3)
15. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V & Le Bourhis X 2000 FGF signals for cell proliferation and migration through different pathways. Cytokine & Growth Factor Reviews 11 295-302. (doi:10.1016/S1359-6101(00)00014-9)
16. Boo YC & Jo H 2003 Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. American Journal of Physiology 285 C499-C508. (doi:10.1152/ajpcell.00122.2003)
17. Brownbill P, McKeeman GC, Brockelsby JC, Crocker IP & Sibley CP 2007 Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology 148 4734-4744. (doi:10.1210/en.2007-0180)
18. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J & Ahmed A 2001 Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. American Journal of Pathology 159 993-1008. (doi:10.1016/S0002-9440(10)61775-0)
19. CampsM, Nichols A & Arkinstall S 2000 Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB Journal 14 6-16.
20. Challier JC, Kacemi A & Olive G 1995 Mixed culture of pericytes and endothelial cells from fetal microvessels of the human placenta. Cellular and Molecular Biology 41 233-241.
21. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D et al. 2003 Endothelial cell diversity revealed by global expression profiling. PNAS 100 10623-10628. (doi:10.1073/pnas.1434429100)
22. Cho US & Xu W 2007 Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 445 53-57. (doi:10.1038/nature05351)
23. Cobb MH 1999 MAP kinase pathways. Progress in Biophysics and Molecular Biology 71 479-500. (doi:10.1016/S0079-6107(98)00056-X)
24. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE & Mosher MD 1993 Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB Journal 7 566-571.
25. Cross MJ, Dixelius J, Matsumoto T & Claesson-Welsh L 2003 VEGF-receptor signal transduction. Trends in Biochemical Sciences 28 488-494. (doi:10.1016/S0968-0004(03)00193-2)
26. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I & Gimenez-Gallego G 1991 Hypotensive activity of fibroblast growth factor. Science 254 1808-1810. (doi:10.1126/science.1957172)
27. D'Angelo G, Struman I, Martial J & Weiner RI 1995 Activation of mitogenactivated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. PNAS 92 6374-6378. (doi:10.1073/pnas.92.14.6374)
28. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathway. Journal of Biological Chemistry 268 14553-14556.
29. Dembinska-Kiec A, Dulak J, Partyka L, Huk I & Mailnski T 1997 VEGFnitric oxide reciprocal regulation. Nature Medicine 3 1177. (doi:10.1038/nm1197-1177a)
30. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R & Zeiher AM 1999 Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 399 601-605. (doi:10.1038/21224)
31. Du MR, Zhou WH, Yan FT, Zhu XY, He YY, Yang JY & Li DJ 2007 Cyclosporin A induces titin expression via MAPK/ERK signaling and improves proliferative and invasive potential of human trophoblast cells. Human Reproduction 22 2528-2537. (doi:10.1093/humrep/dem222)
32. Dulak J & Jozkowicz A 2003 Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxidants & Redox Signaling 5 123-132. (doi:10.1089/152308603321223612)
33. Dye JF, Vause S, Johnston T, Clark P, Firth JA, D'Souza SW, Sibley CP & Glazier JD 2004 Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells. FASEB Journal 18 125-127. (doi:10.1096/fj.02-0916fje)
34. Farivar AS, Mackinnon-Patterson BC, Barnes AD, McCourtie AS & Mulligan MS 2005 Cyclosporine modulates the response to hypoxiareoxygenation in pulmonary artery endothelial cells. Annals of Thoracic Surgery 79 1010-1016. (doi:10.1016/j.athoracsur.2004.08.078)
35. Ferrara N, Gerber HP & LeCouter J 2003 The biology of VEGF and its receptors. Nature Medicine 9 669-676. (doi:10.1038/nm0603-669)
36. Fong GH, Rossant J, Gertsenstein M & Breitman ML 1995 Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 66-70. (doi:10.1038/376066a0)
37. Frank S, Stallmeyer B, Kampfer H, Schaffner C & Pfeilschifter J 1999 Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochemical Journal 338 367-374. (doi:10.1042/0264-6021:3380367)
38. Frey RS, Ushio-Fukai M & Malik AB 2009 NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxidants & Redox Signaling 11 791-810. (doi:10.1089/ars.2008.2220)
39. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL & Jain RK 2001 Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. PNAS 98 2604-2609. (doi:10.1073/pnas.041359198)
40. Fukuo K, Inoue T, Morimoto S, Nakahashi T, Yasuda O, Kitano S, Sasada R & Ogihara T 1995 Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. Journal of Clinical Investigation 95 669-676. (doi:10.1172/JCI117712)
41. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A & Sessa WC 1999 Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 597-601. (doi:10.1038/21218)
42. Fulton D, Gratton JP & Sessa WC 2001 Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? Journal of Pharmacology and Experimental Therapeutics 299 818-824.
43. Gabel S, Benefield J, Meisinger J, Petruzzelli GJ & Young M 1999 Protein phosphatases 1 and 2A maintain endothelial cells in a resting state, limiting the motility that is needed for the morphogenic process of angiogenesis. Otolaryngology - Head and Neck Surgery 121 463-468. (doi:10.1016/S0194-5998(99)70238-X)
44. Gary-Gouy H, Sainz-Perez A, Bismuth G, Ghadiri A, Perrino BA & Dalloul A 2006 Cyclosporin-A inhibits ERKphosphorylation in B cells by modulating the binding of Raf protein to Bcl2. Biochemical and Biophysical Research Communications 344 134-139. (doi:10.1016/j.bbrc.2006.03.121)
45. Gille H, Kowalski J, Yu L, Chen H, Pisabarro MT, Davis-Smyth T & FerraraN 2000 A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factordependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. EMBO Journal 19 4064-4073. (doi:10.1093/emboj/19.15.4064)
46. Gotz J, Probst A, Ehler E, Hemmings B & Kues W 1998 Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit C alpha. PNAS 95 12370-12375. (doi:10.1073/pnas.95.21.12370)
47. Graef IA, Chen F, Chen L, Kuo A & Crabtree GR 2001 Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105 863-875. (doi:10.1016/S0092-8674(01)00396-8)
48. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K & Sessa WC 2001 Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. Journal of Biological Chemistry 276 30359-30365. (doi:10.1074/jbc.M009698200)
49. Greif DM, Kou R & Michel T 2002 Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites. Biochemistry 41 15845-15853. (doi:10.1021/bi026732g)
50. Hernandez GL, Volpert OV, Iniguez MA, Lorenzo E, Martinez-MartInez S, Grau S, Fresno M & Redondo JM 2001 Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. Journal of Experimental Medicine 193 607-620. (doi:10.1084/jem.193.5.607)
51. Hida A, Kawakami A, Miyashita T, Yamasaki S, Nakashima K, Tanaka F, Izumi Y, Tamai M, Huang M, Ida H et al. 2004 Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis. Journal of Laboratory and Clinical Medicine 144 148-155. (doi:10.1016/j.lab.2004.04.009)
52. Illi B, Dello Russo C, Colussi C, Rosati J, Pallaoro M, Spallotta F, Rotili D, Valente S, Ragone G, Martelli F et al. 2008 Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circulation Research 102 51-58. (doi:10.1161/CIRCRESAHA.107.157305)
53. Im SH & Rao A 2004 Activation and deactivation of gene expression by calcium-calcineurin-NFAT-mediated signaling. Molecular Cell 18 1-9.
54. Issbrucker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HC, Suttorp N & ClaussM2003 p38 MAP kinase - a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB Journal 17 262-264. (doi:10.1096/fj.02-0329fje)
55. Itoh H, Zheng J, Bird IM, Nakao K & Magness RR 1999 Basic fibroblast growth factor down-regulates the expression of clearance receptor of natriuretic peptides via mitogen-activated protein kinase cascade in ovine feto-placental artery endothelial cells. American Journal of Physiology 277 R541-R547.
56. Janssens V & Goris J 2001 Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemistry Journal 353 417-439. (doi:10.1042/0264-6021:3530417)
57. Kacemi A, Galtier M, Espie MJ & Challier JC 1997 Isolation of villous microvessels from the human placenta. Comptes Rendus des Séances de l'Académie des Sciences. Série III, Sciences de la Vie 320 171-177.
58. Kadota O, Ohta S, Kumon Y, Sakaki S, Matsuda S & Sakanaka M 1995 Role of basic fibroblast growth factor in the regulation of rat basilar artery tone in vivo. Neuroscience Letters 199 99-102. (doi:10.1016/0304-3940(95)12040-B)
59. Kawasaki K, Smith RS Jr, Hsieh CM, Sun J, Chao J & Liao JK 2003 Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Molecular and Cellular Biology 23 5726-5737. (doi:10.1128/MCB.23.16.5726-5737.2003)
60. Kiely B, Feldman G & Ryan MP 2003 Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporin A-induced increase in transepithelial resistance. Kidney International 63 908-916. (doi:10.1046/j.1523-1755.2003.00804.x)
61. Kimura H & Esumi H 2003 Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochimica Polonica 50 49-59.
62. KlagsbrunM& D'Amore PA 1991 Regulators of angiogenesis. Annual Review of Physiology 53 217-239. (doi:10.1146/annurev.ph.53.030191.001245)
63. Klein S, Roghani M & Rifkin DB 1997 Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. EXS 79 159-192.
64. Kopincova J, Puzserova A & Bernatova I 2011 Biochemical aspects of nitric oxide synthase feedback regulation by nitric oxide. Interdisciplinary Toxicology 4 63-68. (doi:10.2478/v10102-011-0012-z)
65. Kostyk SK, Kourembanas EL, Medeiros WD, McQuilllan LP, D'Amore PA & Braunhut SJ 1995 Basic fibroblast growth factor increases nitric synthase production in bovine endothelial cells. American Journal of Physiology 269 H1583-H1589.
66. Kou R, Greif D & Michel T 2002 Dephosphorylation of endothelial nitricoxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. Journal of Biological Chemistry 277 29669-29673. (doi:10.1074/jbc.M204519200)
67. Kyriakis JM & Avruch J 1996 Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18 567-577. (doi:10.1002/bies.950180708)
68. Lang I, Pabst MA, Hiden U, Blaschitz A, Dohr G, Hahn T & Desoye G 2003 Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. European Journal of Cell Biology 82 163-173. (doi:10.1078/0171-9335-00306)
69. Lang I, Schweizer A, Hiden U, Ghaffari-Tabrizi N, Hagendorfer G, Bilban M, Pabst MA, Korgun ET, Dohr G & Desoye G 2008 Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 76 1031-1043. (doi:10.1111/j.1432-0436.2008.00302.x)
70. Lechward K, Awotunde OS, Swiatek W & Muszynska G 2001 Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochimica Polonica 48 921-933.
71. Lee T, Kim SJ & Sumpio BE 2003 Role of PP2A in the regulation of p38 MAPK activation in bovine aortic endothelial cells exposed to cyclic strain. Journal of Cellular Physiology 194 349-355. (doi:10.1002/jcp.10211)
72. Leidi M, Mariotti M & Maier JA 2010 EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated human endothelial cells. European Journal of Cell Biology 89 654-660. (doi:10.1016/j.ejcb.2010.05.001)
73. Li Y, Zheng J, Bird IM & Magness RR 2003 Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells. Biology of Reproduction 691053-1059. (doi:10.1095/biolreprod.102.013474)
74. Li Y, Zheng J, Bird IM & Magness RR 2004 Mechanisms of shear stressinduced eNOS phosphorylation and expression in ovine feto-placental artery endothelial cells. Biology of Reproduction 70 785-796. (doi:10.1095/biolreprod.103.022293)
75. Liao Y & Hung MC 2004 A new role of protein phosphatase 2A in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells. Cancer Research 64 5938-5942. (doi:10.1158/0008-5472.CAN-04-1533)
76. Liao WX, Feng L, Zhang HH, Zheng J, Moore TR & Chen DB 2009 Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro. Molecular Endocrinology 23 1428-1444. (doi:10.1210/me.2008-0475)
77. Liao WX, Feng L, Zheng J & Chen DB 2010 Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor. Endocrinology 151 3432-3444. (doi:10.1210/en.2009-1305)
78. Liu Y, Shepherd EG & Nelin LD 2007 MAPK phosphatases - regulating the immune response. Nature Reviews. Endocrinology 7 202-212. (doi:10.1038/nri2035)
79. Magness RR 1998 Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. In Endocrinology of Pregnancy, ch 18, pp 507-539. Ed Fuller BW. Totowa, NJ: Humana Press.
80. Magness RR & Zheng J 1996 Circulatory changes during gestation. In Scientific Basis of Pediatric and Perinatal Medicine, 2nd edn, pp 762-772. Eds Gluckman PD & Heymann MA. London: Edward Arnold Publishers.
81. Manjunath N, Wu H, Subramanya S & Shankar P 2009 Lentiviral delivery of short hairpin RNAs. Advanced Drug Delivery Reviews 61 732-745. (doi:10.1016/j.addr.2009.03.004)
82. Mata-Greenwood E, Liao WX, Zheng J & Chen DB 2008 Differential activation of multiple signaling pathways dictates eNOS upregulation by FGF2 but not VEGF in placental artery endothelial cells. Placenta 29 708-717. (doi:10.1016/j.placenta.2008.05.005)
83. Mata-Greenwood E, Liao WX, Zheng J & Chen DB 2010 Activation of AP-1 transcription factors differentiates FGF2 and VEGF regulation of endothelial nitric oxide synthase expression in placental artery endothelial cells. Journal of Biological Chemistry 285 17348-17358. (doi:10.1074/jbc.M109.092791)
84. Matsumoto T, Turesson I, Book M, Gerwins P & Claesson-Welsh L 2002 p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. Journal of Cellular Biology 156 149-160. (doi:10.1083/jcb.200103096)
85. Meschia G 2004 Placental respiratory gas and exchange and fetal oxyenation. In Maternal-Fetal Medicine: Principles and Practice, 5th edn, pp 199-207. Eds Creasy RK, Resnik R, Iams JD. Philadelphia: Elsevier Health Sciences.
86. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PO, Kemp BE & Pearson RB 1999 The Akt kinase signals directly to endothelial nitric oxide synthase. Current Biology 9 845-848. (doi:10.1016/S0960-9822(99)80371-6)
87. Michell BJ, Chen ZB, Tiganis T, Stapleton D, Katsis F, Power DA, Simi AT & Kemp BE 2001 Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. Journal of Biological Chemistry 276 17625-17628. (doi:10.1074/jbc.C100122200)
88. Molkentin JD 2004 Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovascular Research 63 467-475. (doi:10.1016/j.cardiores.2004.01.021)
89. Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K & Sessa WC 2000 Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circulation Research 86 892-896. (doi:10.1161/01.RES.86.8.892)
90. Morris KV 2009 RNA-directed transcriptional gene silencing and activation in human cells. Oligonucleotides 19 299-306. (doi:10.1089/oli.2009.0212)
91. Murata K, Mills I & Sumpio BE 1996 Protein phosphatase 2A in stretchinduced endothelial cell proliferation. Journal of Cellular Biochemistry 63 311-319. (doi:10.1002/(SICI)1097-4644(19961201)63:3<311::AIDJCB6>3.0.CO;2-)
92. Murohara T, Asahara T, Silver M, Bauters C,Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC et al. 1998 Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. Journal of Clinical Investigation 101 2567-2578. (doi:10.1172/JCI1560)
93. Myatt L 1992 Control of vascular resistance in the human placenta. Placenta 13 329-341. (doi:10.1016/0143-4004(92)90057-Z)
94. Myatt L, Brockman DE, Eis AL & Pollock JS 1993 Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14 487-495. (doi:10.1016/S0143-4004(05)80202-4)
95. Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M & Morishita R 2003 Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108 2250-2257. (doi:10.1161/01.CIR.0000093190.53478.78)
96. Noiri E, Hu Y, Bahou WF, Keese CR, Giaever I & Goligorsky MS 1997 Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. Journal of Biological Chemistry 272 1747-1752. (doi:10.1074/jbc.272.3.1747)
97. Osol G & Mandala M 2009 Maternal uterine vascular remodeling during pregnancy. Physiology 24 58-71. (doi:10.1152/physiol.00033.2008)
98. Pacher P, Beckman JS & Liaudet L 2007 Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87 315-424. (doi:10.1152/physrev.00029.2006)
99. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F & Ziche M 1998 Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. Journal of Biological Chemistry 273 4220-4226. (doi:10.1074/jbc.273.7.4220)
100. dela Paz NG & D'Amore PA 2009 Arterial versus venous endothelial cells. Cell and Tissue Research 335 5-16. (doi:10.1007/s00441-008-0706-5)
101. Perrino BA, Wilson AJ, Ellison P & Clapp LH 2002 Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit. European Journal of Biochemistry 269 3540-3548. (doi:10.1046/j.1432-1033.2002.03040.x)
102. Pipili-Synetos E, Sakkoula E & Maragoudakis ME 1993 Nitric oxide is involved in the regulation of angiogenesis. British Journal of Pharmacology 108 855-857.
103. Powers CJ,McLeskey SW &Wellstein A 2000 Fibroblast growth factors, their receptors and signaling. Endocrine-Related Cancer 7 165-197. (doi:10.1677/erc.0.0070165)
104. Rafiee P, Heidemann J, Ogawa H, Johnson NA, Fisher PJ, Li MS, Otterson MF, Johnson CP & Binion DG 2004 Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Communication and Signaling 2 3. (doi:10.1186/1478-811X-2-3)
105. Ravi K, Brennan LA, Levic S, Ross PA & Black SM 2004 S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. PNAS 101 2619-2624. (doi:10.1073/pnas.0300464101)
106. Reynolds LP & Redmer DA 1995 Utero-placental vascular development and placental function. Journal of Animal Science 73 1839-1851.
107. Reynolds LP, Borowicz PP, Vonnahme KA, Johnson ML, Grazul-Bilska AT, Redmer DA & Caton JS 2005 Placental angiogenesis in sheep models of compromised pregnancy. Journal of Physiology 565 43-58. (doi:10.1113/jphysiol.2004.081745)
108. Rocha SF & Adams RH 2009 Molecular differentiation and specialization of vascular beds. Angiogenesis 12 139-147. (doi:10.1007/s10456-009-9132-x)
109. Rosenfeld CR, Morriss FH, Makowski EL, Meschia G & Battaglia FC 1974 Circulatory changes in the reproductive tissues of ewes during pregnancy. Gynecologic Investigation 5 252-268. (doi:10.1159/000301658)
110. Rousseau S, Houle F, Landry J & Huot J 1997 p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15 2169-2177. (doi:10.1038/sj.onc.1201380)
111. Rousseau S, Houle F, Kotanides H, Witte L,Waltenberger J, Landry J &Huot J 2000 Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. Journal of Biological Chemistry 275 10661-10672. (doi:10.1074/jbc.275.14.10661)
112. Sa G, Murugesan G, Jaye M, Ivashchenko Y & Fox PL 1995 Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. Journal of Biological Chemistry 270 2360-2366. (doi:10.1074/jbc.270.5.2360)
113. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M,Wu XF, Breitman ML & Schuh AC 1995 Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 62-66. (doi:10.1038/376062a0)
114. Sheehy AM, Burson MA & Black SM 1998 Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide. American Journal of Physiology 274 L833-L841.
115. Shi Y 2009 Serine/threonine phosphatases: mechanism through structure. Cell 139 468-484. (doi:10.1016/j.cell.2009.10.006)
116. Silverstein AM, Barrow CA, Davis AJ & Mumby MC 2002 Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. PNAS 99 4221-4226. (doi:10.1073/pnas.072071699)
117. Sladek SM, Magness RR & Conrad KP 1997 Nitric oxide and pregnancy. American Journal of Physiology 272 R441-R463.
118. Song Y, Wang K, Chen DB, Magness RR & Zheng J 2009 Suppression of protein phosphatase 2 does not affect VEGF- and FGF2-stimulated ovine fetoplacental artery endothelial cell proliferation. Placenta 30 907-913. (doi:10.1016/j.placenta.2009.07.003)
119. Sontag E 2001 Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cellular Signalling 13 7-16. (doi:10.1016/S0898-6568(00)00123-6)
120. Souttou B, Raulais D & Vigny M 2001 Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways. Journal of Cellular Physiology 187 59-64. (doi:10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F)
121. Sprague BJ, Phernetton TM, Magness RR & Chesler NC 2009 The effects of the ovarian cycle and pregnancy on uterine vascular impedance and uterine artery mechanics. European Journal of Obstetrics and Gynecology 144 S184-S191. (doi:10.1016/j.ejogrb.2009.02.041)
122. Sprague B, Chesler NC & Magness RR 2010 Shear stress regulation of nitric oxide production in uterine and placental artery endothelial cells: experimental studies and hemodynamic models of shear stresses on endothelial cells. International Journal of Developmental Biology 54 331-339. (doi:10.1387/ijdb.082832bs)
123. Szukiewicz D, Szewczyk G, Watroba M, Kurowska E & Maslinski S 2005 Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecologic and Obstetric Investigation 59 102-107. (doi:10.1159/000082622)
124. Tanaka K, Abe M & Sato Y 1999 Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Japanese Journal of Cancer Research 90 647-654. (doi:10.1111/j.1349-7006.1999.tb00796.x)
125. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T & Isner JM 1997 Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Medicine 3 879-886. (doi:10.1038/nm0897-879)
126. Tuder RM, Flook BE & Voelkel NF 1995 Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. Journal of Clinical Investigation 95 1798-1807. (doi:10.1172/JCI117858)
127. Ugele B & Lange F 2001 Isolation of endothelial cells from human placental microvessels: effect of different proteolytic enzymes on releasing endothelial cells from villous tissue. In Vitro Cellular & Developmental Biology. Animal 37 408-413. (doi:10.1290/1071-2690(2001)037<0408:IOECFH>2.0.CO;2)
128. Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher AM, Kaszkin M & Dimmeler S 2002 Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB Journal 16 706-708. (doi:10.1096/fj.01-0637fje)
129. Van Kanegan MJ, Adams DG,Wadzinski BE & Strack S 2005 Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. Journal of Biological Chemistry 280 36029-36036. (doi:10.1074/jbc.M506986200)
130. Vivanco I & Sawyers CL 2002 The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Reviews. Cancer 2 489-501. (doi:10.1038/nrc839)
131. Vonnahme KA, Wilson ME, Li Y, Rupnow HL, Phernetton TM, Ford SP & Magness RR 2005 Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. Journal of Physiology 565 101-109. (doi:10.1113/jphysiol.2004.082321)
132. Wang Y & Zhao S 2010 Vascular biology of the placenta. In Integrated Systems Physiology: from Molecules to Function to Disease. Eds Granger DN & Granger J. San Rafael: Morgan & Claypool Life Sciences. (doi:10.4199/C00016ED1V01Y201008ISP009)
133. Wang X, Athayde N & Trudinger B 2003 A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. American Journal of Obstetrics and Gynecology 189 1445-1451. (doi:10.1067/S0002-9378(03)00652-5)
134. Wang K, Song Y, Chen DB & Zheng J 2008 Protein phosphatase 3 differentially modulates vascular endothelial growth factor and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells. Biology of Reproduction 79 704-710. (doi:10.1095/biolreprod.108.068957)
135. Wang K, Jiang YZ, Chen DB & Zheng J 2009 Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MAP2K1/2/MAPK3/1 and PI3K/AKT1 pathways. Placenta 30 1045-1051. (doi:10.1016/j.placenta.2009.10.007)
136. Wen HC, Huang WC, Ali A, Woodgett JR & Lin WW 2003 Negative regulation of phosphatidylinositol 3-kinase and Akt signaling pathway by PKC. Cellular Signalling 15 37-45. (doi:10.1016/S0898-6568(02)00047-5)
137. Wilkins BJ & Molkentin JD 2004 Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochemical and Biophysical Research Communications 322 1178-1191. (doi:10.1016/j.bbrc.2004.07.121)
138. Williams DJ, Vallance PJ, Neild GH, Spencer JA & Imms FJ 1997 Nitricoxide mediated vasodilation in human pregnancy. American Journal of Physiology 272 H748-H752.
139. Yashima R, Abe M, Tanaka K, Ueno H, Shitara K, Takenoshita S & Sato Y 2001 Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells. Journal of Cellular Physiology 188 201-210. (doi:10.1002/jcp.1107)
140. Young MR, Kolesiak K & Meisinger J 2002 Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes. International Journal of Cancer 100 276-282. (doi:10.1002/ijc.10491)
141. Zarlingo TJ, Eis AL, Brockman DE, Kossenjans W & Myatt L 1997 Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta 18 511-520. (doi:10.1016/0143-4004(77)90004-2)
142. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z & Chopp M 2003 Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circulation Research 92 308-313. (doi:10.1161/01.RES.0000056757.93432.8C)
143. Zheng J, Vagnoni KE, Bird IM & Magness RR 1997 Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-1 receptors in the ovine placenta during the third trimester of pregnancy. Biology of Reproduction 56 1189-1197. (doi:10.1095/biolreprod56.5.1189)
144. Zheng J, Bird IM, Melsaether AM & Magness RR 1999 Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for bFGF and EGF stimulated expression of endothelial nitric oxide synthase. Endocrinology 140 1399-1407. (doi:10.1210/en.140.3.1399)
145. Zheng J, Yun L, Weiss AR, Bird IM & Magness RR 2000 Expression of endothelial and inducible nitric oxide synthase and nitric oxide production in the ovine placental and uterine tissues during late pregnancy. Placenta 21 516-524. (doi:10.1053/plac.1999.0504)
146. Zheng J, Bird IM, Chen DB & Magness RR 2005 Angiotensin II regulation of fetoplacental artery endothelial functions. Journal of Physiology 565 59-69. (doi:10.1113/jphysiol.2004.082420)
147. Zheng J, Wen YX, Austin JL & Chen DB 2006 Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen activated protein kinase pathway in ovine fetoplacental artery endothelial cells. Biology of Reproduction 74 375-382. (doi:10.1095/biolreprod.105.043190)
148. Zheng J, Wen YX, Song Y, Wang K, Chen DB & Magness RR 2008 Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation. Biology of Reproduction 78 143-150. (doi:10.1095/biolreprod.107.064477)
149. Ziche M, Morbidelli L, Masini E, Granger HJ, Geppetti P & Ledda F 1993 Nitric oxide promotes DNA synthesis and cycle GMP formation in endothelial cells from postcapillary venules. Biochemical and Biophysical Research Communications 192 1198-1203. (doi:10.1006/bbrc.1993.1543)
150. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P & Ledda F 1994 Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. Journal of Clinical Investigation 94 2036-2044. (doi:10.1172/JCI117557)
151. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ & Bicknell R 1997a Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factorinduced angiogenesis. Journal of Clinical Investigation 99 2625-2634. (doi:10.1172/JCI119451)
152. Ziche M, Parenti A, Ledda F, Dell'Era P, Granger HJ, Maggi CA & Presta M 1997b Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circulation Research 80 845-852. (doi:10.1161/01.RES.80.6.845)
153. Zubilewicz A, Hecquet C, Jeanny JC, Soubrane G, Courtois Y & Mascarelli F 2001 Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF. Oncogene 20 1403-1413. (doi:10.1038/sj.onc.1204231)